Peer-influenced content. Sources you trust. No registration required. This is HCN.
British Medical Journal (The BMJ)
“Selecting a GLP-1 receptor agonist over another antihyperglycemic drug could plausibly confer ancillary benefit” in patients at high risk for or living with an SUD. — Study authors
Endocrinology, Diabetes, Metabolism March 18th 2026
MDLinx
“Second-line therapy should not be dismissed outright in platinum-refractory or early-relapsing disease. It remains a relevant part of comprehensive care.” — Tingting Tan, MD, PhD, City of Hope
Internal Medicine March 17th 2026
Hematology Advisor
“Extreme endurance exercise pushes red blood cells toward accelerated aging through mechanisms that mirror what we observe during blood storage.” — Angelo D’Alessandro, PhD, University of Colorado Anschutz
Cardiology March 17th 2026
Medical News Today (MNT)
“It gives clinicians objective clinical evidence guidance as to the risks and benefits of napping and catching up on sleep during weekends.” — Kaushik Govindaraju, DO, Medical Offices of Manhattan
Endocrinology, Diabetes, Metabolism March 16th 2026
News Medical
“This guideline is a road map to help clinicians navigate these advances for the safest and most effective approaches to care.” — Mark A. Creager, MD, Dartmouth Health
Emergency Medicine March 16th 2026
“We show that following the guidelines as a whole benefits public health — a sustainable Nordic diet benefits public health and the climate.” — Christina Dahm, Associate Professor, Aarhus University
Family Medicine/General Practice March 16th 2026